Kolexia
Robert Alexandre
Anesthesie-réanimation
Centre Hospitalier de Cannes
Cannes, France
36 Activités
32 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hémorragie COVID-19 Choc Choc septique Pneumopathie infectieuse Thrombose Sepsie Syndrome de détresse respiratoire de l'adulte Thromboembolie

Industries

Pfizer
2 collaboration(s)
Dernière en 2023
Sanofi
1 collaboration(s)
Dernière en 2022
Alexion
1 collaboration(s)
Dernière en 2021
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Protocol for fever control using external cooling in mechanically ventilated patients with septic shock: SEPSISCOOL II randomised controlled trial.
BMJ open   29 janvier 2024
Fever Control Using External Cooling in Mechanically Ventilated Patients With Septic Shock: Intérêt du Traitement de la fièvre Par Refroidissement Externe Pour la Survie Des Patients ventilés en Choc Septique
Essai Clinique (Centre Hospitalier Intercommunal Creteil)   19 octobre 2023
Prone positioning effects on oxygenation and respiratory mechanics according to the R/I ratio in patients with acute respiratory distress syndrome
Proceedings of Reanimation 2023, the French Intensive Care Society International Congress   14 juin 2023
Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical Trial.
JAMA internal medicine   07 juin 2023
CoVInnate: Role of Inflammasomes in COVID-19 Disease
Essai Clinique (CHU Nice)   20 mars 2023
Systemic Infection Model to Study Altered Virulence during Polymicrobial Infection by .
Pathogens (Basel, Switzerland)   02 mars 2023
ANTICOVID: ANTIcoagulation in Severe COVID-19 Patients: a Multicenter, Parallel-group, Open-label, Randomized Controlled Trial
Essai Clinique (Assistance publique – Hôpitaux de Paris)   05 septembre 2022
Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trial.
BMJ open   26 avril 2022
Assessment of Magnetic Resonance Imaging Changes and Functional Outcomes Among Adults With Severe Herpes Simplex Encephalitis.
JAMA network open   01 juillet 2021
Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity.
Blood advances   16 mars 2021